Paolo Lombardo

Paolo Lombardo


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MTMarina Talamonti
Marina Talamonti
MGMarco Galluzzo
Marco Galluzzo
DSDionisio Silvaggio
Dionisio Silvaggio
PLPaolo Lombardo
Paolo Lombardo
CTChiara Tartaglia
Chiara Tartaglia
LBLuca Bianchi
Luca Bianchi
Atopic dermatitis (AD) is a dermatological disorder that affects patients’ mental health and psychological state in complex ways. The importance of understanding the entire scope of this burden is well recognized, but there is limited comprehensive information about the resulting stress on adult patients with AD. This study aimed to determine the degree of psychological stress in patients with AD compared to healthy participants. A total of 352 adult patients participated in this cross-sectional study—174 with AD and 178 healthy participants. Demographic and clinical data were collected. Itch and sleep disturbance were assessed using a numeric rating scale and a visual analogue scale. The 20-item Toronto Alexithymia Scale (TAS-20) and Beck Depression Inventory (BDI) questionnaires were administered to assess the symptoms of alexithymia and depression. Quality of life (QOL) was assessed in AD patients using the Dermatology Quality Index. In our study, we found high TAS-20 and BDI scores among patients with AD. The prevalence of alexithymic personality features was 56.3% in patients with AD versus 21.3% in healthy controls (p < 0.001). Based on BDI scoring (BDI-21 > 13), depression was suspected in a significantly higher number of patients with AD than in the control group (56.9% (99/174) vs. 15.7% (28/178); p < 0.0001). Eczema Area and Severity Index (EASI) score did not show any significant correlations with psychological parameters. Among clinical parameters, only sleep disturbance was positively correlated with depression (R = 0.307, p < 0.005). Our data show that the severity index score as a representative factor of skin involvement has a limited role in predicting the effect of skin diseases on mental status. Screening and assessment for psychiatric disorders, QOL, and sleep disturbance in patients with atopic dermatitis cannot be neglected by physicians and they should be treated in clinical practice with the consideration of psychosomatic approaches.

Verified
Journal Article
Open access
PDF file
MRMaria Cristina Rapanotti
Maria Cristina Rapanotti
ECElisa Cugini
Elisa Cugini
MNMarzia Nuccetelli
Marzia Nuccetelli
Alessandro TerrinoniAlessandro Terrinoni
Alessandro Terrinoni
CRCosimo Di Raimondo
Cosimo Di Raimondo
LBLuca Bianchi
Luca Bianchi
Human malignant melanoma shows a high rate of mortality after metastasization, and its incidence is continuously rising worldwide. Several studies have suggested that MCAM/MUC18/CD146 plays an important role in the progression of this malignant disease. MCAM/MUC18/CD146 is a typical single-spanning transmembrane glycoprotein, existing as two membrane isoforms, long and short, and an additional soluble form, sCD146. We previously documented that molecular MCAM/MUC18/CD146 expression is strongly associated with disease progression. Recently, we showed that MCAM/MUC18/CD146 and ABCB5 can serve as melanoma-specific-targets in the selection of highly primitive circulating melanoma cells, and constitute putative proteins associated with disease spreading progression. Here, we analyzed CD146 molecular expression at onset or at disease recurrence in an enlarged melanoma case series. For some patients, we also performed the time courses of molecular monitoring. Moreover, we explored the role of soluble CD146 in different cohorts of melanoma patients at onset or disease progression, rather than in clinical remission, undergoing immune therapy or free from any clinical treatment. We showed that MCAM/MUC18/CD146 can be considered as: (1) a membrane antigen suitable for identification and enrichment in melanoma liquid biopsy; (2) a highly effective molecular “warning” marker for minimal residual disease monitoring; and (3) a soluble protein index of inflammation and putative response to therapeutic treatments.

5 June 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
CRCosimo Di Raimondo
Cosimo Di Raimondo
PLPaolo Lombardo
Paolo Lombardo
CTCristiano Tesei
Cristiano Tesei
FEFabiana Esposito
Fabiana Esposito
FMFederico Meconi
Federico Meconi
MCMaria Cantonetti
Maria Cantonetti
Background: The neutrophil/lymphocyte ratio (NLR) at baseline has been demonstrated to correlate with higher stages of disease and to be a prognostic factor in numerous cancers. However, its function as a prognostic factor for mycosis fungoides (MF) has not been yet clarified. Objective: Our work aimed to assess the association of the NLR with different stages of MF and to outline whether higher values of this marker are related to a more aggressive MF. Methods: We retrospectively calculated the NLRs in 302 MF patients at the moment of diagnosis. The NLR was obtained using the complete blood count values. Results: The median NLR among patients with early stage disease (low-grade IA-IB-IIA) was 1.88, while the median NLR for patients with high-grade MF (IIB-IIIA-IIIB) was 2.64. Statistical analysis showed positive associations of advanced MF stages with NLRs higher than 2.3. Conclusions: Our analysis demonstrates that the NLR represents a cheap and easily available parameter functioning as a marker for advanced MF. This might guide physicians in recognizing patients with advanced stages of disease requiring a strict follow-up or an early treatment.

1 April 2021 in Italian Journal of Dermatology and Venereology
Verified
Journal Article
Closed access
GSGiulia Spallone
Giulia Spallone
AVAlessandra Ventura
Alessandra Ventura
MMMauro Mazzeo
Mauro Mazzeo
CRCosimo DI Raimondo
Cosimo DI Raimondo
PLPaolo Lombardo
Paolo Lombardo
LBLuca Bianchi
Luca Bianchi
Article: Cancer duplicity: a case of chronic lymphocytic leukemia and metastatic melanoma treated with Ipilimumab - Italian Journal of Dermatology and Venereology 2021 February;156(1):112-3 - Minerva Medica - Journals